PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Surveillance of adverse events following immunisation in Australia annual report, 2014.

Abstract This report summarises Australian passive surveillance data for adverse events following immunisation (AEFI) for 2014 reported to the Therapeutic Goods Administration for 2014 and describes reporting trends over the 15-year period 1 January 2000 to 31 December 2014. There were 3,087 AEFI records for vaccines administered in 2014; an annual AEFI reporting rate of 13.2 per 100,000 population. There was a decline of 5% in the overall AEFI reporting rate in 2014 compared with 2013. This decline in reported adverse events in 2014 compared with the previous year was mainly attributable to fewer reports following the human papillomavirus (HPV) vaccine as it was the 2nd year of the extension of the National HPV Vaccination Program to males. AEFI reporting rates for most vaccines were lower in 2014 compared with 2013. The most commonly reported reactions were injection site reaction (27%), pyrexia (18%), rash (16%), vomiting (9%), headache (7%), and syncope (5%). The majority of AEFI reports described non-serious events while 7% (n=211) were classified as serious. There were 5 deaths reported with no clear causal relationship with vaccination found.
PMID
Related Publications

Annual report: surveillance of adverse events following immunisation in Australia, 2009.

Annual report: Surveillance of adverse events following immunisation in Australia, 2011.

Annual report: Surveillance of adverse events following immunisation in Australia, 2005.

Annual report: surveillance of adverse events following immunisation in Australia, 2007.

Surveillance of adverse events following immunisation in Australia annual report, 2013.

Authors

Mayor MeshTerms

Public Health Surveillance

Keywords
Journal Title communicable diseases intelligence quarterly report
Publication Year Start




PMID- 28278414
OWN - NLM
STAT- MEDLINE
DA  - 20170309
DCOM- 20170317
LR  - 20170317
IS  - 1447-4514 (Print)
IS  - 1447-4514 (Linking)
VI  - 40
IP  - 3
DP  - 2016 Sep 30
TI  - Surveillance of adverse events following immunisation in Australia annual report,
      2014.
PG  - E377-E390
AB  - This report summarises Australian passive surveillance data for adverse events
      following immunisation (AEFI) for 2014 reported to the Therapeutic Goods
      Administration for 2014 and describes reporting trends over the 15-year period 1 
      January 2000 to 31 December 2014. There were 3,087 AEFI records for vaccines
      administered in 2014; an annual AEFI reporting rate of 13.2 per 100,000
      population. There was a decline of 5% in the overall AEFI reporting rate in 2014 
      compared with 2013. This decline in reported adverse events in 2014 compared with
      the previous year was mainly attributable to fewer reports following the human
      papillomavirus (HPV) vaccine as it was the 2nd year of the extension of the
      National HPV Vaccination Program to males. AEFI reporting rates for most vaccines
      were lower in 2014 compared with 2013. The most commonly reported reactions were 
      injection site reaction (27%), pyrexia (18%), rash (16%), vomiting (9%), headache
      (7%), and syncope (5%). The majority of AEFI reports described non-serious events
      while 7% (n=211) were classified as serious. There were 5 deaths reported with no
      clear causal relationship with vaccination found.
FAU - Dey, Aditi
AU  - Dey A
AD  - National Centre for Immunisation Research and Surveillance of Vaccine Preventable
      Diseases, University of Sydney and The Children's Hospital at Westmead, Sydney,
      New South Wales.
FAU - Wang, Han
AU  - Wang H
AD  - National Centre for Immunisation Research and Surveillance of Vaccine Preventable
      Diseases, University of Sydney and The Children's Hospital at Westmead, Sydney,
      New South Wales.
FAU - Quinn, Helen E
AU  - Quinn HE
AD  - National Centre for Immunisation Research and Surveillance of Vaccine Preventable
      Diseases, University of Sydney and The Children's Hospital at Westmead, Sydney,
      New South Wales.
FAU - Hill, Richard
AU  - Hill R
AD  - Pharmacovigilance and Special Access Branch, Therapeutic Goods Administration,
      Canberra, Australian Capital Territory.
FAU - Macartney, Kristine K
AU  - Macartney KK
AD  - National Centre for Immunisation Research and Surveillance of Vaccine Preventable
      Diseases, University of Sydney and The Children's Hospital at Westmead, Sydney,
      New South Wales.
LA  - eng
PT  - Journal Article
DEP - 20160930
PL  - Australia
TA  - Commun Dis Intell Q Rep
JT  - Communicable diseases intelligence quarterly report
JID - 101601804
RN  - 0 (Vaccines)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Adverse Drug Reaction Reporting Systems
MH  - Aged
MH  - Australia/epidemiology
MH  - Bacterial Infections/epidemiology/immunology/microbiology/*prevention & control
MH  - Child
MH  - Edema/chemically induced/diagnosis/physiopathology
MH  - Exanthema/chemically induced/diagnosis/physiopathology
MH  - Female
MH  - Fever/chemically induced/diagnosis/physiopathology
MH  - Headache/chemically induced/diagnosis/physiopathology
MH  - Humans
MH  - Infant
MH  - Male
MH  - Middle Aged
MH  - *Public Health Surveillance
MH  - Seasons
MH  - Time Factors
MH  - Vaccination/*statistics & numerical data
MH  - Vaccines/administration & dosage/*adverse effects
MH  - Virus Diseases/epidemiology/immunology/*prevention & control/virology
MH  - Vomiting/chemically induced/diagnosis/physiopathology
EDAT- 2017/03/10 06:00
MHDA- 2017/03/18 06:00
CRDT- 2017/03/10 06:00
PST - epublish
SO  - Commun Dis Intell Q Rep. 2016 Sep 30;40(3):E377-E390.

<?xml version="1.0" encoding="UTF-8"?>
<b:Sources SelectedStyle="" xmlns:b="http://schemas.openxmlformats.org/officeDocument/2006/bibliography"  xmlns="http://schemas.openxmlformats.org/officeDocument/2006/bibliography" >
</b:Sources>